Literature DB >> 26104996

Fungal contamination of nebuliser devices used by people with cystic fibrosis.

D Peckham1, K Williams1, S Wynne1, M Denton2, K Pollard1, R Barton3.   

Abstract

BACKGROUND: Poor nebuliser hygiene can result in bacterial contamination and risk of infections. The aim of this study was to assess the prevalence of fungal contamination of nebulisers used by adults with cystic fibrosis.
METHODS: A total of 170 nebulisers from 149 subjects were screened by wetting a sterile cotton swab with sterile water and swabbing each drug chamber. The swab was then plated out on Sabouraud and on Scel+agar and incubated at 27 °C for up to 2 weeks.
RESULTS: Fungal cultures were positive in 86 (57.7%) patient's devices. In 28/149 (18.8%), 39/149 (26.2%), 47/149 (31.5%) and 20/149 (13.4%) of subjects Aspergillus species, yeasts, moulds and both yeasts and moulds were isolated respectively. There was no difference in contamination rates between different devices.
CONCLUSION: Nebuliser devices are frequently contaminated by moulds and yeasts and emphasis should be placed on ensuring adequate nebuliser hygiene.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Biofilm; Device; Fungi; Nebuliser

Mesh:

Substances:

Year:  2015        PMID: 26104996     DOI: 10.1016/j.jcf.2015.06.004

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  7 in total

1.  Evaluation of disinfectants for elimination of fungal contamination of patient beds in a reference hospital in Piauí, Brazil.

Authors:  Ismael da Silva Aquino; Jhonatas Cley Santos Porto; Jacksony Lima da Silva; Khaiohana Fontinele Costa Morais; Frâncio Alencar Coelho; Thiago de Sousa Lopes; Ivonizete Pires Ribeiro; Iraci Salmito Noleto; Maria do Amparo Salmito; Mitra Mobin
Journal:  Environ Monit Assess       Date:  2016-10-28       Impact factor: 2.513

2.  Inhaled antibiotic use is associated with Scedosporium/Lomentospora species isolation in cystic fibrosis.

Authors:  Gina Hong; Noah Lechtzin; Denis Hadjiliadis; Steven M Kawut
Journal:  Pediatr Pulmonol       Date:  2018-12-14

Review 3.  Nebuliser hygiene in cystic fibrosis: evidence-based recommendations.

Authors:  Jane Bell; Lauren Alexander; Jane Carson; Amanda Crossan; John McCaughan; Hazel Mills; Damian O'Neill; John E Moore; B Cherie Millar
Journal:  Breathe (Sheff)       Date:  2020-06

Review 4.  Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis.

Authors:  Carsten Schwarz; Dominik Hartl; Olaf Eickmeier; Andreas Hector; Christian Benden; Isabelle Durieu; Amparo Sole; Silvia Gartner; Carlos E Milla; Peter James Barry
Journal:  Mycopathologia       Date:  2017-07-31       Impact factor: 2.574

5.  Nebuliser cleaning and disinfection practice in the home among patients with cystic fibrosis.

Authors:  Mary MacFarlane; Lesley Carson; Amanda Crossan; Jane Bell; John E Moore; B Cherie Millar
Journal:  J Infect Prev       Date:  2019-06-21

6.  Harnessing Bacterial Signals for Suppression of Biofilm Formation in the Nosocomial Fungal Pathogen Aspergillus fumigatus.

Authors:  F Jerry Reen; John P Phelan; David F Woods; Rachel Shanahan; Rafael Cano; Sarah Clarke; Gerard P McGlacken; Fergal O'Gara
Journal:  Front Microbiol       Date:  2016-12-22       Impact factor: 5.640

7.  Cleaning and infection control of airway clearance devices used by CF patients.

Authors:  Eynav Manor; Michal Gur; Yuval Geffen; Lea Bentur
Journal:  Chron Respir Dis       Date:  2017-05-17       Impact factor: 2.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.